The Neuropathology Core (NP Core) of the Udall Center for Excellence in Parkinson's Disease Research at Mayo Clinic will perform postmortem evaluation of brains of participants in the Udall Center and provide neuropathologic support for research projects. The characterization of brain tissue will employ routine neurohistologic methods, as well as immunohistochemistry, image analysis, biochemistry (fractionation and immunoblot analyses of synuclein and tau) and unbiased stereology.
The specific aims are as follows: 1.) Perform standardized diagnostic neuropathologic evaluations and data collection for all brains harvested locally or sent to the Udall Center by referring physicians. As part of this process, the NP Core will perform immunostaining of cortical, hippocampal and basal forebrain sections with alpha-synuclein antibodies to record density of Lewy bodies in multiple cortical regions, as well as presence and sevedty of Lewy neurites in hippocampus, basal forebrain, striatum and amygdala. It will characterize non-Lewy body Parkinsonian degenerative disorders with immunocytochemistry and semiquantitative assessment of the density and distribution of neuronal and glial lesions. On all cases it will also assess concurrent Alzheimer type pathology with quantitative indices for senile plaque and neurofibrillary tangles in multiple cortical and subcortical areas, as well as assign a Braak neurofibrillary tangle stage. It will use validated neuropathologic research criteria for those disorders for which such criteria have been established and """"""""best clinical practice"""""""" criteria for uncommon disorders for which research criteria do not yet exist. 2.) Provide human tissue samples to Projects by Farrer, Dickson, and Yen. 3.) The NP Core will provide fixed and frozen brain samples to qualified investigators studying Parkinson's disease and other parkinsonian disorders as approved by the Executive Committee of the Administration, Data Management and Statistics Core. 5.) The NP Core will provide data to a possible future national database linking a minimal dataset from the various Udall Centers.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
5P50NS040256-08
Application #
7277633
Study Section
Special Emphasis Panel (ZNS1)
Project Start
Project End
Budget Start
2006-09-01
Budget End
2007-08-31
Support Year
8
Fiscal Year
2006
Total Cost
$54,867
Indirect Cost
Name
Mayo Clinic Jacksonville
Department
Type
DUNS #
153223151
City
Jacksonville
State
FL
Country
United States
Zip Code
32224
Verma, Manish; Callio, Jason; Otero, P Anthony et al. (2017) Mitochondrial Calcium Dysregulation Contributes to Dendrite Degeneration Mediated by PD/LBD-Associated LRRK2 Mutants. J Neurosci 37:11151-11165
Sanchez-Contreras, Monica; Heckman, Michael G; Tacik, Pawel et al. (2017) Study of LRRK2 variation in tauopathy: Progressive supranuclear palsy and corticobasal degeneration. Mov Disord 32:115-123
Hassan, Anhar; Heckman, Michael G; Ahlskog, J E et al. (2016) Association of Parkinson disease age of onset with DRD2, DRD3 and GRIN2B polymorphisms. Parkinsonism Relat Disord 22:102-5
Yue, M; Hinkle, K M; Davies, P et al. (2015) Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice. Neurobiol Dis 78:172-95
Cornejo-Olivas, Mario R; Torres, Luis; Mata, Ignacio F et al. (2015) A Peruvian family with a novel PARK2 mutation: Clinical and pathological characteristics. Parkinsonism Relat Disord 21:444-8
Verma, Manish; Steer, Erin K; Chu, Charleen T (2014) ERKed by LRRK2: a cell biological perspective on hereditary and sporadic Parkinson's disease. Biochim Biophys Acta 1842:1273-81
Foroutan, Parastou; Murray, Melissa E; Fujioka, Shinsuke et al. (2013) Progressive supranuclear palsy: high-field-strength MR microscopy in the human substantia nigra and globus pallidus. Radiology 266:280-8
Jiang, Peizhou; Gan, Ming; Ebrahim, Abdul Shukkur et al. (2013) Adenosine monophosphate-activated protein kinase overactivation leads to accumulation of ýý-synuclein oligomers and decrease of neurites. Neurobiol Aging 34:1504-15
Whitwell, Jennifer L; Xu, Jia; Mandrekar, Jay et al. (2013) Frontal asymmetry in behavioral variant frontotemporal dementia: clinicoimaging and pathogenetic correlates. Neurobiol Aging 34:636-9
Sundal, Christina; Fujioka, Shinsuke; Van Gerpen, Jay A et al. (2013) Parkinsonian features in hereditary diffuse leukoencephalopathy with spheroids (HDLS) and CSF1R mutations. Parkinsonism Relat Disord 19:869-77

Showing the most recent 10 out of 205 publications